In a new in-depth article Michele Romano, PhD, responsible at BÜHLMANN for the Product Management of the CAST® Assays for Basophil Activation Tests (BAT), writes about the benefits of using BAT assays in drug discovery and preclinical evaluation of kinase inhibitors.